Surgery
Volume 147, Issue 2 , Pages 181-184 , February 2010

Contribution of biologically derived nanoparticles to disease

  • Maria K. Schwartz, PhD

      Affiliations

    • Department of Physiology and Biomedical Engineering, Rochester, MN
    • ,
  • John C. Lieske, MD

      Affiliations

    • Department of General Internal Medicine, Division of Nephrology, Mayo Clinic, Rochester, MN
    • ,
  • Virginia M. Miller, PhD

      Affiliations

    • Department of Physiology and Biomedical Engineering, Rochester, MN
    • Department of Surgery, Mayo Clinic, Rochester, MN
    • Corresponding Author InformationReprint requests: Virginia M. Miller, PhD, Department of Surgery, Medical Science Building 4-62, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

,Accepted 9 July 2009.

References 

  1. Liu J, Levine AL, Mattoon JS, Yamaguchi M, Lee RJ, Pan X, et al. Nanoparticles as image enhancing agents for ultrasonography. Phys Med Biol. 2006;51:2179–2189
  2. Peters D, Kastantin M, Kotamraju VR, Karmali PP, Gujraty K, Tirrell M, et al. Targeting atherosclerosis by using modular, multifunctional micelles. Proc Natl Acad Sci U S A. 2009;106:9815–9819
  3. Wang G, Siggers K, Zhang S, Jiang H, Xu Z, Zernicke RF, et al. Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating. Pharm Res. 2008;25:2896–2909
  4. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622–627
  5. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev. 2007;21:157–171
  6. Folk RL. Bacteria and nannobacteria revealed in hardgrounds, calcite cements, native sulfur, sulfide minerals, and travertines. Geolog Soc Am. 1992;24:104
  7. Kajander EO, Kuronen I, Åkerman K, Pelttari A, Ciftcioglu N. Nanobacteria from blood, the smallest culturable autonomously replicating agent on Earth. Proc SPIE. 1997;3111:420–428
  8. McKay DS, Gibson EK, Thomas-Keprta KL, Vali H, Romanek CS, Clemett SJ, et al. Search for past life on Mars: possible relic biogenic activity in martian meteorite ALH84001. Science. 1996;273:924–930
  9. Raoult D, Drancourt M, Azza S, Nappez C, Guieu R, Rolain JM, et al. Nanobacteria are mineralo fetuin complexes. PLoS Pathog. 2008;4:e41
  10. Martel J, Young JD. Purported nanobacteria in human blood as calcium carbonate nanoparticles. Proc Natl Acad Sci U S A. 2008;105:5549–5554
  11. Miller VM, Rodgers G, Charlesworth JA, Kirkland B, Severson SR, Rasmussen TE, et al. Evidence of nanobacterial-like structures in human calcified arteries and cardiac valves. Am J Physiol Heart Circ Physiol. 2004;287:H1115–H1124
  12. Folk RL. Nannobacteria in the natural environment and in medicine. Alpe Adria Microbiol J. 1998;7:87–95
  13. Bratos-Perez MA, Sanchez PL, Garcia de Cruz S, Villacorta E, Palacios IF, Fernandez-Fernandez JM, et al. Association between self-replicating calcifying nanoparticles and aortic stenosis: a possible link to valve calcification. Eur Heart J. 2008;29:371–376
  14. Ciftcioglu N, Bjorklund M, Kuorikoski K, Bergstrom K, Kajander EO. Nanobacteria: an infectious cause for kidney stone formation. Kidney Intl. 1999;56:1893–1898
  15. Kumar V, Farell G, Yu S, Harrington S, Fitzpatrick L, Rzewuska E, et al. Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles. J Investig Med. 2006;54:412–424
  16. Wang L, Shen W, Wen J, An X, Cao L, Wang B. An animal model of black pigment gallstones caused by nanobacteria. Dig Dis Sci. 2006;51:1126–1132
  17. Sedivy R, Battistutti WB. Nanobacteria promote crystallization of psammoma bodies in ovarian cancer. APMIS. 2003;111:951–954
  18. Shoskes DA, Thomas KD, Gomez E. Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol. 2005;173:474–477
  19. Deva A, Chang L. Bacterial biofilms: a cause for accelerated capsular contracture?. Aesthetic Surg J. 1999;19:130–133
  20. Beck JD, Offenbacher S. The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review. Ann Periodontol. 2001;6:9–15
  21. Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti GM, Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol. 2000;20:1417–1420
  22. Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation. 2002;106:184–190
  23. Muhlestein JB, Anderson JL. Chronic infection and coronary artery disease. Cardiol Clin. 2003;21:333–362
  24. Pajkos A, Deva AK, Vickery K, Cope C, Chang L, Cossart YE. Detection of subclinical infection in significant breast implant capsules. Plast Reconstr Surg. 2003;111:1605–1611
  25. Del Pozo JL, Tran NV, Petty PM, Johnson CH, Walsh MF, Bite U, et al. Pilot study of association of bacteria on breast implants with capsular contracture. J Clin Microbiol. 2009;47:1333–1337
  26. Cisar JO, Xu DQ, Thompson J, Swaim W, Hu L, Kopecko DJ. An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci U S A. 2000;97:11511–11515
  27. Young JD, Martel J, Young L, Wu CY, Young A, Young D. Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis. PLoS One. 2009;4:e4417
  28. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–1322
  29. Braxton EE, Ehrlich GD, Hall-Stoodley L, Stoodley P, Veeh R, Fux C, et al. Role of biofilms in neurosurgical device-related infections. Neurosurg Rev. 2005;28:249–255
  30. Garcia-Lechuz J, Bouza E. Treatment recommendations and strategies for the management of bone and joint infections. Expert Opin Pharmacother. 2009;10:35–55
  31. Norowski PA, Bumgardner JD. Biomaterial and antibiotic strategies for peri-implantitis: a review. J Biomed Mater Res B Appl Biomater. 2009;88:530–543
  32. Beathard GA, Urbanes A. Infection associated with tunneled hemodialysis catheters. Semin Dial. 2008;21:528–538
  33. Bjorklund M, Ciftcioglu N, Kajander EO. Extraordinary survival of nanobacteria under extreme conditions. SPIE. 1998;3441:123–129
  34. Bobryshev YV, Lord RS, Tran D. Chlamydia pneumoniae in foci of “early” calcification of the tunica media in arteriosclerotic arteries: an incidental presence?. Am J Physiol Heart Circ Physiol. 2006;290:H1510–H1519
  35. Mattila KJ, Valle MS, Nieminen MS, Valtonen VV, Hietaniemi KL. Dental infections and coronary atherosclerosis. Atherosclerosis. 1993;103:205–211
  36. Spiewak R, Dutkiewicz J. In vitro study of pro-inflammatory and anti-tumour properties of microvesicles from bacterial cell wall of Pantoea agglomerans. Ann Agric Environ Med. 2008;15:153–161
  37. Jayachandran M, Litwiller RD, Owen WG, Heit JA, Behrenbeck T, Mulvagh SL, et al. Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol. 2008;295:H931–H938
  38. Grice EA, Kong HH, Renaud G, Young AC, Program NCS, Bouffard GG, et al. A diversity profile of the human skin microbiota. Genome Res. 2008;18:1043–1050
  39. Grimes DJ. Koch's postulates—then and now. Microbe. 2006;1:223–228
  40. Shiekh FA, Khullar M, Singh SK. Lithogenesis: induction of renal calcifications by nanobacteria. Urol Res. 2006;34:53–57
  41. Schwartz MA-K, Lieske JC, Kumar V, Farell-Baril G, Miller VM. Human-derived nanoparticles and vascular responses to injury in rabbit carotid arteries: proof of principle. Int J Nanomedicine. 2008;3:243–248
  42. Schwartz MK, Lieske JC, Hunter LW, Miller VM. Systemic injection of planktonic forms of mammalian-derived nanoparticles alters arterial response to injury in rabbits. Am J Physiol Heart Circ Physiol. 2009;296:H1434–H1441
  43. Hill AB. The environment and disease: association or causation?. Proc R Soc Med. 1965;58:295–300

 Supported in part by research grants from the National Institutes of Health (HL88988); the Fetzer Foundation; the Division of Surgical Research, Mayo Clinic; and the Mayo Foundation and the College of Medicine, Mayo Clinic.

PII: S0039-6060(09)00451-6

doi: 10.1016/j.surg.2009.07.009

Surgery
Volume 147, Issue 2 , Pages 181-184 , February 2010

Article Tools

* Image Usage & Resolution